Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Aduhelm
Aduhelm
With its Aduhelm proposal, Medicare is stepping into a heated debate about how best to improve equity in Alzheimer’s treatment
Stat
Fri, 01/14/22 - 10:56 am
Medicare
Aduhelm
Biogen
CMS
racial disparity
Alzheimer's disease
Biogen leaders warn sales teams: Only 2,000 patients might access Aduhelm over the next several years
Endpoints
Thu, 01/13/22 - 10:26 pm
Biogen
Aduhelm
CMS
drug reps
Medicare
Alzheimer's disease
For Biogen's Aduhelm, narrow coverage from CMS 'could effectively spell the end': analyst
Fierce Pharma
Wed, 01/12/22 - 11:01 am
CMS
Biogen
Aduhelm
Medicare
clinical trials
Alzheimer's disease
Medicare proposes to limit coverage of Biogen Alzheimer's drug
BioPharma Dive
Tue, 01/11/22 - 10:22 pm
Biogen
Aduhelm
CMS
Medicare
5 questions facing the FDA in 2022
BioPharma Dive
Tue, 01/11/22 - 10:20 pm
FDA
regulatory
Robert Califf
Biogen
Aduhelm
JPM22: Pfizer's big bet on mRNA, Biogen 'proven wrong' on Aduhelm price and the next cell therapies
BioPharma Dive
Mon, 01/10/22 - 11:52 pm
JPMHC 2022
Pfizer
MRNA
Biogen
Aduhelm
cell therapy
Biogen's Aduhelm faces a key coverage decision next week. Which way will Medicare rule, and how much does it matter?
Fierce Pharma
Thu, 01/6/22 - 12:59 pm
Biogen
Aduhelm
Medicare
CMS
Alzheimer's disease
Biogen-Eisai's potential Aduhelm sequel drug granted speedy review by FDA
Fierce Biotech
Tue, 12/28/21 - 10:55 am
Biogen
Eisai
lecanemab
FDA
Aduhelm
fast track
Alzheimer's disease
2022 forecast: How marketers must learn from Biogen's marketing struggles with Aduhelm
Fierce Pharma
Mon, 12/27/21 - 11:10 am
Biogen
Aduhelm
pharma marketing
Alzheimer's disease
Roche
Eli Lilly
What’s Behind Biogen’s Move To Cut Prices On Its Controversial Alzheimer’s Drug Aduhelm?
Forbes
Sun, 12/26/21 - 11:16 pm
Biogen
Aduhelm
drug pricing
Alzheimer's disease
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators
Fierce Pharma
Wed, 12/22/21 - 11:06 am
Biogen
Eisai
Aduhelm
Japan
Alzheimer's disease
Alzheimer's experts call on FDA to pull Biogen's Aduhelm
Endpoints
Tue, 12/21/21 - 10:31 am
Biogen
Aduhelm
FDA
Alzheimer's disease
Biogen halves Aduhelm's price and plots cost cuts as Medicare decision on controversial Alzheimer's drug nears
Fierce Pharma
Mon, 12/20/21 - 11:11 am
Biogen
Aduhelm
Alzheimer's disease
drug pricing
layoffs
Biogen’s Alzheimer’s drug Aduhelm is rejected by EU advisors
Pharmaforum
Fri, 12/17/21 - 11:11 am
Biogen
Aduhelm
Europe
Alzheimer's disease
Biogen hits the gas pedal on Aduhelm confirmatory trial, hoping to deliver results in 2026
Fierce Pharma
Thu, 12/16/21 - 12:09 pm
Biogen
Aduhelm
FDA
clinical trials
Alzheimer's disease
Biogen Eyes Massive Layoffs in Wake of Disappointing Aduhelm Rollout
BioSpace
Wed, 12/8/21 - 11:52 pm
Biogen
layoffs
Aduhelm
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
Motley Fool
Sun, 11/28/21 - 11:03 pm
Roche
Biogen
Alzheimer's disease
Aduhelm
gantenerumab
Study: Biogen’s Aduhelm Caused Brain Swelling in Over One-Third of Study Participants
BioSpace
Mon, 11/22/21 - 10:31 pm
Biogen
Aduhelm
brain swelling
ARIA-edema
Alzheimer's disease
Biogen seeking more information in investigation of Aduhelm patient's death
BioPharma Dive
Sat, 11/20/21 - 11:58 am
Biogen
Aduhelm
patient deaths
Alzheimer's disease
Major Insurers Weigh in on “Medical Necessity” of Biogen’s Aduhelm
BioSpace
Sat, 11/20/21 - 11:57 am
Biogen
Aduhelm
insurers
Alzheimer's disease
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »